Medical Fraud Rings: Transnational Fraud

The most dangerous fraud rings in healthcare today don’t operate out of a single clinic, city, or even country. They operate everywhere at once, and they’re getting harder to catch.

Transnational durable medical equipment (DME) fraud has emerged as one of the most sophisticated and costly threats facing health insurers, federal programs, and patients alike.

Unlike traditional healthcare fraud, which tends to be localized and opportunistic, transnational DME fraud is orchestrated, scalable, and deliberately designed to evade detection. Understanding how it works — and why conventional defenses fall short — is the first step toward building a response equal to the threat.

Transnational DME Fraud: What Is It?

It starts with a real Medicare beneficiary, let’s call her Maria, 71, diabetic, living in Miami. She never ordered a wheelchair. She never met a DME supplier. But somewhere, her Medicare number is attached to $14,000 in claims, a prescription signed by a doctor in another state, and clinical notes identical to 847 other patients. She is being used as a fraudulent alibi. And she has no idea.

Durable medical equipment fraud involves the submission of fraudulent claims for medical equipment — wheelchairs, braces, CPAP machines, diabetic supplies, and more. Supplies that were never medically necessary, never properly ordered, or never actually delivered to a patient.

Transnational DME fraud takes this a step further. These are coordinated criminal enterprises that operate across multiple countries, using networks of shell companies, stolen patient identities, and complicit or unwitting providers to generate billions of dollars in fraudulent Medicare, Medicaid, and private insurance claims each year.

The U.S. Department of Justice and Department of Health and Human Services have identified transnational fraud rings (many with ties to Cuba, Venezuela, and other countries) as a primary driver of DME fraud losses. In one of the largest healthcare fraud takedowns in U.S. history, federal authorities charged over 600 defendants in connection with approximately $2 billion in fraudulent DME billing.

How Transnational DME Fraud Rings Operate

What makes these schemes particularly dangerous is their operational sophistication.

1. Identity harvesting at scale. Fraud rings begin by acquiring large volumes of patient and provider data, often purchased on dark web marketplaces or obtained through data breaches. These stolen identities form the foundation for claim submissions: real Medicare beneficiary numbers paired with fraudulent DME orders.
2. Telemedicine and prescriber fraud. Many modern transnational schemes exploit telehealth infrastructure to generate the physician orders required for DME claims.
3. Criminal networks either recruit physicians to sign orders in bulk for patients they’ve never seen or they forge signatures entirely. Either way, the result is thousands of “valid” prescriptions generated in days instead of months.
4. Shell company networks. Fraud rings register DME supplier companies, often using stolen or synthetic identities and enroll them as Medicare or Medicaid providers, and begin billing immediately. Once a supplier starts attracting scrutiny, it is dissolved and replaced. The network may operate dozens of such entities simultaneously across multiple states.
5. Copy-paste documentation. One of the most reliable red flags in transnational DME fraud is the use of identical or near-identical clinical notes across hundreds or thousands of patient records. Legitimate clinical documentation reflects the individual patient: their history, symptoms, and the provider’s clinical notes. Fraudulent documentation looks like cookie-cutter symptoms for billing at scale.
6. Money movement across borders. Once claims are paid, proceeds are rapidly moved through layered financial transactions – wire transfers, cryptocurrency, and cash often going back to coordinators operating outside U.S. jurisdiction. This cross-border money flow is what gives transnational fraud its staying power: even when individual suppliers are prosecuted, the financial beneficiaries are frequently unreachable.

The 6 Red Flags You Need to Know

For those on the front lines of DME fraud detection, several indicators warrant elevated scrutiny:

• Suppliers with no physical presence or a registered address at a virtual office or mail drop
• Prescriber patterns where a single physician generates orders for DME suppliers in multiple states, particularly for patients they have never seen in person
• Identical clinical documentation across large patient populations
• Rapid enrollment and early high-volume billing from newly registered DME suppliers
• Beneficiary addresses concentrated in specific zip codes with no clear clinical rationale
• Claims for high-cost DME categories such as orthotic braces, power wheelchairs, and diabetic supplies which carry the highest reimbursement and the highest fraud risk.

Keep in mind: None of these signals is conclusive on its own. Transnational DME fraud is best detected through the convergence of multiple anomalies across a network.

The Stakes Are Too High for a Static Defense

Healthcare fraud costs the U.S. an estimated $100 billion or more annually, and DME fraud specifically accounts for a disproportionate share of those losses. The consequences are real — and so is the accountability. In a recent South Florida case, a DME company owner was sentenced to 55 months in federal prison after billing Medicare for over $2.2 million in equipment that was never provided in just five months. Over $1.4 million had already been paid out before the scheme was stopped. Justice came, but the damage was already done. That’s the cost of detection after the fact. The goal has to be catching these schemes before claim one is ever paid.

This article is part of our medical provider fraud webinar series. Click here for future webinars covering additional fraud rings, detection strategies, and industry case studies.

Check out our sources:

Durable Medical Equipment Company Owner Sentenced for Health Care Fraud.” Oversight.gov, U.S. Department of Health & Human Services Office of Inspector General, 12 Oct. 2022, Oversight.gov article. Accessed 7 May 2026.